Invention Grant
- Patent Title: Cell lines and their use in encapsulated cell biodelivery
- Patent Title (中): 细胞系及其在胶囊细胞生物传递中的应用
-
Application No.: US13145669Application Date: 2010-01-21
-
Publication No.: US08741340B2Publication Date: 2014-06-03
- Inventor: Philip Kusk , Lars Ulrik Wahlberg
- Applicant: Philip Kusk , Lars Ulrik Wahlberg
- Applicant Address: DK Ballerup
- Assignee: NsGene A/S
- Current Assignee: NsGene A/S
- Current Assignee Address: DK Ballerup
- Agency: Clark & Elbing LLP
- Agent Kristina Bieker-Brady
- Priority: DK200900103 20090123; DK200970121 20090922
- International Application: PCT/DK2010/050013 WO 20100121
- International Announcement: WO2010/083841 WO 20100729
- Main IPC: C12N5/10
- IPC: C12N5/10 ; C12P21/00 ; C12N15/85 ; A61K9/48 ; A61K48/00
Abstract:
The present invention relates to generation of cell lines expressing recombinant proteins for use in naked and encapsulated cell biodelivery of secreted therapeutic molecules. In one embodiment the cell line is human. In another aspect of the invention the transposon system is used for generating a cell line for secretion of a biologically active polypeptide.
Public/Granted literature
- US20120027847A1 CELL LINES AND THEIR USE IN ENCAPSULATED CELL BIODELIVERY Public/Granted day:2012-02-02
Information query
